Prostate specific antigen (PSA) is an important biomarker for diagnosis and prognosis of prostate can- cer. Herein, microcontact PSA-imprinted surface plasmon resonance (SPR) sensor chip was developed for sensitive, real-time detection of PSA. The imprinted chip was prepared in the presence of methacrylic acid (MAA) as functional monomer and ethylene glycol dimethacrylate (EGDMA) as cross-linker via UV poly- merization using microcontact imprinting technique. PSA imprinted SPR sensor chip was characterized by atomic force microscope (AFM), scanning electron microscope (SEM), ellipsometry, dispersive Raman and Fourier transform infrared spectroscopy (FT-IR). Under optimal conditions, PSA detection was per- formed with standard PSA solutions in the concentration range of 0.1–50 ng mL−1 with a detection limit (LOD) of approximately 91 pg mL−1 (18 × 10−14 M). Selectivity studies were performed against human serum albumin (HSA) and lysozyme (Lyz) as the competitive agents. The developed system was evalu- ated for analysis of 10 clinical serum samples and showed approximately 98% agreement between the results obtained by commercial enzyme-linked immunosorbent assay (ELISA) method without significant differences at the 0.05 significance level (p = 0.751, p > 0.05).
New Article in Sensors and Actuators B: Chemical
Article is about, Microcontact imprinting based surface plasmon resonance (SPR) biosensor for real-time and ultrasensitive detection of prostate specific antigen (PSA) from clinical samples
Bioreg Newsletter
The year at BIOREG, in your inbox.
Papers, theses, awards and congresses in one yearly issue, plus announcements when something is open. See past issues.


